Mannkind (MNKD) Depreciation and Depletion (2015 - 2026)
Mannkind (MNKD) reported Depreciation and Depletion of $2.0 million for Q1 2026, down 2.09% year-over-year from $2.1 million in Q1 2025, and up 1.15% on a QoQ basis from $2.0 million in Q4 2025.
Mannkind (MNKD) has 12 years of Depreciation and Depletion data on file, last reported at $2.0 million in Q1 2026.
- Quarterly Depreciation and Depletion fell 2.09% year-over-year to $2.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.1 million (up 0.51% YoY) and the FY2025 annual result came in at $8.1 million, up 10.96% from the prior year.
- Depreciation and Depletion climbed to $2.0 million in Q1 2026 per MNKD's latest filing, from $2.0 million in the prior quarter.
- Across five years, Depreciation and Depletion topped out at $2.1 million in Q4 2024 and bottomed at $599000.0 in Q1 2022.
- The 5-year median for Depreciation and Depletion is $1.3 million (2024), against an average of $1.5 million.
- The widest annual swing landed in 2024, when Depreciation and Depletion jumped 87.91%; it then decreased 7.31% in 2025.
- Tracing MNKD's Depreciation and Depletion over 5 years: stood at $1.0 million in 2022, then gained by 22.31% to $1.2 million in 2023, then jumped by 71.92% to $2.1 million in 2024, then dropped by 7.31% to $2.0 million in 2025, then rose by 1.15% to $2.0 million in 2026.
- Per Business Quant, the three latest MNKD Depreciation and Depletion figures stand at $2.0 million (Q1 2026), $2.0 million (Q4 2025), and $2.0 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 1,395.22 |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | - |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | - |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn | 2.02 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.02 Mn |
| Mar 31, 2026 | 2.02 Mn |
| Dec 31, 2025 | 1.99 Mn |
| Dec 31, 2025 | 1.99 Mn |
| Sep 30, 2025 | 2.01 Mn |
| Sep 30, 2025 | 2.01 Mn |
| Jun 30, 2025 | 2.04 Mn |
| Jun 30, 2025 | 2.04 Mn |
| Mar 31, 2025 | 2.06 Mn |
| Mar 31, 2025 | 2.06 Mn |
| Dec 31, 2024 | 2.15 Mn |
| Dec 31, 2024 | 2.15 Mn |
| Sep 30, 2024 | 2.10 Mn |
| Sep 30, 2024 | 2.10 Mn |
| Jun 30, 2024 | 1.71 Mn |
| Jun 30, 2024 | 1.71 Mn |
| Mar 31, 2024 | 1.34 Mn |
| Mar 31, 2024 | 1.34 Mn |
| Dec 31, 2023 | 1.25 Mn |
| Dec 31, 2023 | 1.25 Mn |
| Sep 30, 2023 | 1.12 Mn |
| Sep 30, 2023 | 1.12 Mn |
| Jun 30, 2023 | 1.10 Mn |
| Jun 30, 2023 | 1.10 Mn |
| Mar 31, 2023 | 1.04 Mn |
| Mar 31, 2023 | 1.04 Mn |
| Dec 31, 2022 | 1.02 Mn |
| Dec 31, 2022 | 1.02 Mn |
| Sep 30, 2022 | 952,000.00 |
| Sep 30, 2022 | 952,000.00 |
| Jun 30, 2022 | 727,000.00 |
| Jun 30, 2022 | 727,000.00 |
| Mar 31, 2022 | 599,000.00 |
| Mar 31, 2022 | 599,000.00 |
| Dec 31, 2021 | 551,000.00 |
| Dec 31, 2021 | 551,000.00 |
| Sep 30, 2021 | 508,000.00 |
| Sep 30, 2021 | 508,000.00 |
| Jun 30, 2021 | 481,000.00 |
| Jun 30, 2021 | 481,000.00 |
| Mar 31, 2021 | 460,000.00 |
| Mar 31, 2021 | 460,000.00 |
| Dec 31, 2020 | 454,000.00 |
| Dec 31, 2020 | 454,000.00 |
| Sep 30, 2020 | 445,000.00 |
| Sep 30, 2020 | 445,000.00 |
| Jun 30, 2020 | 448,000.00 |
| Jun 30, 2020 | 448,000.00 |
| Mar 31, 2020 | 443,000.00 |
| Mar 31, 2020 | 443,000.00 |
| Dec 31, 2019 | 465,000.00 |
| Dec 31, 2019 | 465,000.00 |
| Sep 30, 2019 | 396,000.00 |
| Sep 30, 2019 | 396,000.00 |
| Jun 30, 2019 | 371,000.00 |
| Jun 30, 2019 | 371,000.00 |
| Mar 31, 2019 | 367,000.00 |
| Mar 31, 2019 | 367,000.00 |
| Dec 31, 2018 | 411,000.00 |
| Dec 31, 2018 | 411,000.00 |
| Sep 30, 2018 | 404,000.00 |
| Sep 30, 2018 | 404,000.00 |
| Jun 30, 2018 | 445,000.00 |
| Jun 30, 2018 | 445,000.00 |
| Mar 31, 2018 | 400,000.00 |
| Mar 31, 2018 | 400,000.00 |
| Dec 31, 2017 | 450,000.00 |
| Dec 31, 2017 | 450,000.00 |
| Sep 30, 2017 | 454,000.00 |
| Sep 30, 2017 | 454,000.00 |
| Jun 30, 2017 | 450,000.00 |
| Jun 30, 2017 | 450,000.00 |
| Mar 31, 2017 | 446,000.00 |
| Mar 31, 2017 | 446,000.00 |
| Dec 31, 2016 | 625,000.00 |
| Dec 31, 2016 | 625,000.00 |
| Sep 30, 2016 | 597,000.00 |
| Sep 30, 2016 | 597,000.00 |
| Jun 30, 2016 | 589,000.00 |
| Jun 30, 2016 | 589,000.00 |
| Sep 30, 2015 | 3.17 Mn |
| Sep 30, 2015 | 3.17 Mn |